These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20491631)

  • 1. Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets.
    Tolmachev V; Orlova A
    Curr Med Chem; 2010; 17(24):2636-55. PubMed ID: 20491631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting with
    Rezazadeh F; Sadeghzadeh N
    Chem Biol Drug Des; 2019 Mar; 93(3):205-221. PubMed ID: 30299570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.
    Okarvi SM
    Cancer Treat Rev; 2008 Feb; 34(1):13-26. PubMed ID: 17870245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
    de Jong M; Kwekkeboom D; Valkema R; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.
    Ananias HJ; de Jong IJ; Dierckx RA; van de Wiele C; Helfrich W; Elsinga PH
    Curr Pharm Des; 2008; 14(28):3033-47. PubMed ID: 18991717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmaceutical development of radiolabelled peptides.
    Fani M; Maecke HR
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S11-30. PubMed ID: 22388624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and perspectives in peptide receptor radiation therapy.
    Ansquer C; Kraeber-Bodéré F; Chatal JF
    Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers.
    Farahani AM; Maleki F; Sadeghzadeh N
    Anticancer Agents Med Chem; 2020; 20(4):402-416. PubMed ID: 31889492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors.
    Schweinsberg C; Maes V; Brans L; Bläuenstein P; Tourwé DA; Schubiger PA; Schibli R; García Garayoa E
    Bioconjug Chem; 2008 Dec; 19(12):2432-9. PubMed ID: 19053304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled peptides in oncology: role in diagnosis and treatment.
    Weiner RE; Thakur ML
    BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles.
    Ocampo-García B; Ferro-Flores G; Morales-Avila E; Ramírez Fde M
    Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-targeted diagnostics and radiotherapeutics.
    Tweedle MF
    Acc Chem Res; 2009 Jul; 42(7):958-68. PubMed ID: 19552403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
    Kaltsas GA; Papadogias D; Makras P; Grossman AB
    Endocr Relat Cancer; 2005 Dec; 12(4):683-99. PubMed ID: 16322317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide and protein based radiopharmaceuticals.
    Wynendaele E; Bracke N; Stalmans S; De Spiegeleer B
    Curr Pharm Des; 2014; 20(14):2250-67. PubMed ID: 24025103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled carbohydrated somatostatin analogs: a review of the current status.
    Wester HJ; Schottelius M; Poethko T; Bruus-Jensen K; Schwaiger M
    Cancer Biother Radiopharm; 2004 Apr; 19(2):231-44. PubMed ID: 15186604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R; Wang X; Forrer F; Kneifel S; Tamma ML; Waser B; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2009 Aug; 15(16):5240-9. PubMed ID: 19671861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.